4 | Biomarkers (Surrogate Marker)IBA
01/2022
-
09/2011 |
4 | ErbB Receptors (EGF Receptor)IBA
09/2014
-
01/2011 |
2 | Monoclonal AntibodiesIBA
11/2017
-
07/2014 |
2 | Pharmaceutical PreparationsIBA
01/2017
-
11/2014 |
2 | LigandsIBA
01/2015
-
01/2006 |
2 | Epidermal Growth Factor (EGF)IBA
03/2013
-
01/2011 |
2 | Gefitinib (Iressa)FDA Link
01/2011
-
01/2011 |
2 | Proteins (Proteins, Gene)FDA Link
05/2008
-
08/2006 |
2 | Cell Surface ReceptorsIBA
08/2006
-
01/2006 |
1 | globotriaosylceramide (globotriosylceramide)IBA
01/2020 |
1 | Shiga Toxin (Shigella Toxin)IBA
01/2020 |
1 | pertuzumabIBA
11/2017 |
1 | Cetuximab (Erbitux)FDA Link
11/2017 |
1 | Peptides (Polypeptides)IBA
01/2016 |
1 | TARPIBA
01/2016 |
1 | AntigensIBA
01/2016 |
1 | HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2016 |
1 | Formaldehyde (Formol)FDA Link
01/2016 |
1 | T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016 |
1 | ParaffinIBA
01/2016 |
1 | Immunoconjugates (Immunoconjugate)IBA
11/2014 |
1 | Complement System Proteins (Complement)IBA
12/2013 |
1 | Trastuzumab (Herceptin)FDA Link
12/2013 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2013 |
1 | Cys-ZHER2-342 affibodyIBA
04/2013 |
1 | Freund's AdjuvantIBA
01/2012 |
1 | Fibronectins (Fibronectin)IBA
01/2012 |
1 | Tyrosine Kinase InhibitorsIBA
01/2011 |
1 | Radioisotopes (Radionuclides)IBA
09/2009 |
1 | N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
03/2007 |
1 | 111In-benzyl-DTPA-ZHER2:342IBA
05/2006 |